Bespoke Extracts (BSPK) Retained Earnings (2011 - 2025)
Bespoke Extracts (BSPK) reported Retained Earnings of -$26.9 million for Q3 2025, down 2.79% on a YoY basis from -$27.7 million in Q3 2024, and down 210.81% sequentially from $24.3 million in Q2 2025.
Bespoke Extracts (BSPK) Retained Earnings (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Retained Earnings data on file, last reported at -$26.9 million in Q3 2025.
- For the quarter ending Q3 2025, Retained Earnings fell 2.79% year-over-year to -$26.9 million; the trailing twelve-month figure through Sep 2025 stood at -$26.9 million (down 2.79% YoY), and the FY2024 full-year result was $24.3 million, up 195.8% from the prior year.
- Retained Earnings fell to -$26.9 million in Q3 2025, from $24.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $24.3 million in Q1 2025 to a low of -$26.9 million in Q3 2025.
- A 5-year average of -$1.7 million and a median of -$19.3 million in 2021 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 201.6% in 2021, while the deepest fall reached 230.32% in 2021.
- Tracing BSPK's Retained Earnings over 5 years: stood at -$19.5 million in 2021, then surged by 218.89% to $23.2 million in 2022, then sank by 209.33% to -$25.4 million in 2023, then surged by 195.8% to $24.3 million in 2024, then tumbled by 210.89% to -$26.9 million in 2025.
- Business Quant data shows BSPK's Retained Earnings at -$26.9 million in Q3 2025, $24.3 million in Q2 2025, and $24.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -26.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -26.95 Mn |
| Jun 30, 2025 | 24.32 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Dec 31, 2024 | 24.30 Mn |
| Sep 30, 2024 | -26.22 Mn |
| Jun 30, 2024 | -25.94 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | -25.37 Mn |
| Sep 30, 2023 | -25.10 Mn |
| Jun 30, 2023 | -24.79 Mn |
| Mar 31, 2023 | 23.34 Mn |
| Dec 31, 2022 | 23.20 Mn |
| Sep 30, 2022 | -22.89 Mn |
| Jun 30, 2022 | 21.24 Mn |
| Mar 31, 2022 | 20.42 Mn |
| Nov 30, 2021 | -19.52 Mn |
| Aug 31, 2021 | 19.08 Mn |
| May 31, 2021 | -19.58 Mn |
| Feb 28, 2021 | -19.28 Mn |
| Nov 30, 2020 | -18.98 Mn |